Kalaris Therapeutics Inc (KLRS)

Feb 11, 2026

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 11, 2026

Feb 11, 2026

Why Kalaris Therapeutics Inc. stock is trending among retail tradersQuarterly Investment Review & High Return Trade Opportunity Guides - mfd.ru

Feb 11, 2026

Feb 10, 2026

Kalaris Therapeutics Emerges with Focused Retinal Disease Strategy - AD HOC NEWS

Feb 10, 2026

Feb 09, 2026

Institution Moves: Whats the profit margin of Kalaris Therapeutics IncTrade Exit Report & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Feb 09, 2026

Jan 31, 2026

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Increases By 60.8% - MarketBeat

Jan 31, 2026

Jan 31, 2026

Kalaris Therapeutics (NASDAQ:KLRS) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat

Jan 31, 2026

Jan 29, 2026

Smart Money: Should I add Kalaris Therapeutics Inc stock to my portfolioJuly 2025 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn

Jan 29, 2026

Jan 29, 2026

Kalaris to present phase 1 data of novel eye therapy at Macula Society - Investing.com Australia

Jan 29, 2026

Jan 28, 2026

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting - Investing News Network

Jan 28, 2026

Jan 24, 2026

Kalaris Therapeutics (NASDAQ:KLRS) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Jan 24, 2026

Jan 21, 2026

Kalaris Therapeutics raises $50M privately - MSN

Jan 21, 2026

Jan 20, 2026

What’s the MACD signal for Kalaris Therapeutics Inc.Double Top/Bottom Patterns & High Return Capital Strategies - bollywoodhelpline.com

Jan 20, 2026

Jan 17, 2026

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 17, 2026

Jan 14, 2026

Buyback Watch: Will Kalaris Therapeutics Inc outperform small cap indexesJuly 2025 Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 14, 2026

Jan 14, 2026

Block Trades: Can Kalaris Therapeutics Inc weather a recessionWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn

Jan 14, 2026

Jan 13, 2026

Swing Trade: Is Kalaris Therapeutics Inc. affected by consumer sentimentInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn

Jan 13, 2026

Jan 12, 2026

Support Test: What is Kalaris Therapeutics Incs 5 year growth outlookRecession Risk & AI Powered Market Entry Ideas - baoquankhu1.vn

Jan 12, 2026

Jan 09, 2026

How Kalaris Therapeutics Inc. stock responds to policy changesMarket Sentiment Report & Technical Pattern Based Buy Signals - Улправда

Jan 09, 2026

Jan 08, 2026

Why retail investors pile into Kalaris Therapeutics Inc. stockJuly 2025 Trade Ideas & Long-Term Investment Growth Plans - Улправда

Jan 08, 2026

Jan 08, 2026

Is Kalaris Therapeutics Inc. stock a defensive play in 2025Treasury Yields & Reliable Volume Spike Trade Alerts - Улправда

Jan 08, 2026

Dec 31, 2025

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Expands By 26.1% - MarketBeat

Dec 31, 2025

Dec 26, 2025

Analysts’ Weekly Ratings Updates for Kalaris Therapeutics (KLRS) - Defense World

Dec 26, 2025

Dec 25, 2025

Chardan Capital Initiates Coverage on Kalaris Therapeutics (NASDAQ:KLRS) - Defense World

Dec 25, 2025

Dec 24, 2025

Kalaris Therapeutics announces initial data from TH103 trial - MSN

Dec 24, 2025

Dec 24, 2025

Chardan Capital Upgrades Kalaris Therapeutics (NASDAQ:KLRS) to Strong-Buy - MarketBeat

Dec 24, 2025

Dec 23, 2025

Chardan Capital Initiates Coverage of Kalaris Therapeutics (KLRS) with Buy Recommendation - Nasdaq

Dec 23, 2025

Dec 23, 2025

Chardan Initiates Kalaris Therapeutics at Buy With $19 Price Target - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Chardan Capital Markets initiates coverage on Kalaris stock with Buy rating - Investing.com Nigeria

Dec 23, 2025

Dec 23, 2025

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 23, 2025

Dec 23, 2025

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Dec 23, 2025

Dec 21, 2025

Why Kalaris Therapeutics Inc. stock is rated strong buyJuly 2025 Chart Watch & Real-Time Volume Triggers - Улправда

Dec 21, 2025

Dec 20, 2025

KLRS Kalaris Therapeutics Inc +8.76%eToro - eToro

Dec 20, 2025

Dec 20, 2025

Kalaris Therapeutics (NASDAQ:KLRS) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Dec 20, 2025

Dec 20, 2025

Kalaris Therapeutics (NASDAQ:KLRS) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Dec 20, 2025

Dec 20, 2025

Why Kalaris Therapeutics Inc. stock is popular among millennialsJuly 2025 WrapUp & AI Powered Market Entry Strategies - Улправда

Dec 20, 2025

Dec 19, 2025

Will Kalaris Therapeutics Inc. stock deliver long term returnsJuly 2025 Momentum & Comprehensive Market Scan Reports - Улправда

Dec 19, 2025

Dec 19, 2025

Kalaris Therapeutics: Phase 1a Data De-Risks The Path To 2026 Catalysts (KLRS) - Seeking Alpha

Dec 19, 2025

Dec 19, 2025

Targets Report: Why Kalaris Therapeutics Inc. stock is popular among millennialsTrade Performance Summary & Smart Swing Trading Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Latham & Watkins Advises on Kalaris Therapeutics’ US$50 Million Private Placement - Legal Desire Media and Insights

Dec 19, 2025

Dec 19, 2025

Fundamentals Check: Will Kalaris Therapeutics Inc. stock outperform growth indexesJuly 2025 Reactions & Reliable Momentum Entry Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Kalaris Therapeutics: TH103 Trial Success And $50M Raise Set Stage For Growth (KLRS) - Seeking Alpha

Dec 18, 2025

Dec 18, 2025

Kalaris stock price target raised to $26 at Citizens on TH103 data - Investing.com Canada

Dec 18, 2025

Dec 18, 2025

Kalaris Therapeutics Announces Oversubscribed $50 Million Financing - TipRanks

Dec 18, 2025

Dec 18, 2025

Kalaris Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets

Dec 18, 2025

Dec 18, 2025

Kalaris Therapeutics (NASDAQ: KLRS) lines up $50M private placement - Stock Titan

Dec 18, 2025